Wirtz Andrea L, Cooney Erin E, Stevenson Megan, Radix Asa, Poteat Tonia, Wawrzyniak Andrew J, Cannon Christopher M, Schneider Jason S, Haw J Sonya, Case James, Althoff Keri N, Humes Elizabeth, Mayer Kenneth H, Beyrer Chris, Rodriguez Allan E, Reisner Sari L
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Callen-Lorde Community Health Center, New York, NY, United States.
JMIR Res Protoc. 2021 Apr 26;10(4):e29152. doi: 10.2196/29152.
The HIV epidemic disproportionately impacts transgender women in the United States. Cohort studies identify unique risks for affected populations, but use of facility-based methods may bias findings towards individuals living in research catchment areas, more engaged in health services, or, in the case of transgender populations, those who are open about their transgender identity. Digital clinical trials and other online research methods are increasingly common, providing opportunity to reach those not commonly engaged in research. Simultaneously, there is a need to understand potential biases associated with digital research, how these methods perform, and whether they are accepted across populations.
This study aims to assess the feasibility of developing and implementing an online cohort of transgender women to assess risks for HIV acquisition and other health experiences. Further, this study aims to evaluate how an online cohort compares to a site-based, technology-enhanced cohort for epidemiologic research. The overarching goal is to estimate incidence of HIV and other health outcomes among transgender women in eastern and southern United States.
This substudy is part of a larger multisite prospective cohort (LITE) conducted among transgender women, which also includes a site-based, technology-enhanced cohort in 6 eastern and southern US cities. The online cohort was launched to enroll and follow participants across 72 cities in the same region and with similar demographic characteristics as the site-based cohort. Participants are followed for 24 months. Adult transgender women are recruited via convenience sampling (eg, peer referrals, social media, and dating apps). Participants reporting negative or unknown HIV status are enrolled in a baseline study visit, complete a sociobehavioral survey, and provide oral fluid specimens to test for HIV. Participants not living with HIV (lab-confirmed) at baseline are offered enrollment into the cohort; follow-up assessments occur every 6 months.
Enrollment into the online cohort launched in January 2019. Active recruitment stopped in May 2019, and enrollment officially closed in August 2020. A total of 580 participants enrolled into and are followed in the cohort. A recruitment-enrollment cascade was observed across screening, consent, and completion of study activities. Implementation experiences with HIV test kits highlight the need for heavy staff engagement to support participant engagement, visit completion, and retention, even with automated digital procedures.
This study is responsive to increasing research interest in digital observational and intervention research, particularly for populations who are most affected by the HIV epidemic and for those who may otherwise not participate in person. The progression across stages of the recruitment-enrollment cascade provides useful insight for implementation of cohort studies in the online environment.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/29152.
在美国,艾滋病毒疫情对跨性别女性的影响尤为严重。队列研究确定了受影响人群的独特风险,但基于机构的研究方法可能会使研究结果偏向于居住在研究覆盖区域、更多参与卫生服务的个体,或者对于跨性别群体而言,偏向于那些公开自己跨性别身份的人。数字临床试验和其他在线研究方法越来越普遍,为接触那些通常不参与研究的人群提供了机会。同时,有必要了解与数字研究相关的潜在偏差、这些方法的表现如何,以及它们是否被不同人群所接受。
本研究旨在评估建立和实施一个跨性别女性在线队列以评估艾滋病毒感染风险和其他健康经历的可行性。此外,本研究旨在评估在线队列与基于现场的、技术增强型队列在流行病学研究方面的比较情况。总体目标是估计美国东部和南部跨性别女性中艾滋病毒及其他健康结局的发病率。
本亚研究是一项在跨性别女性中开展的更大规模多地点前瞻性队列研究(LITE)的一部分,该研究还包括在美国东部和南部6个城市的一个基于现场的、技术增强型队列。在线队列启动,以招募和跟踪同一地区72个城市且人口特征与基于现场的队列相似的参与者。对参与者进行24个月的随访。成年跨性别女性通过便利抽样(如同伴推荐、社交媒体和约会应用程序)招募。报告艾滋病毒状态为阴性或未知的参与者参加基线研究访视,完成一项社会行为调查,并提供口腔液样本以检测艾滋病毒。基线时未感染艾滋病毒(实验室确诊)的参与者被邀请加入队列;每6个月进行一次随访评估。
在线队列于2019年1月启动招募。2019年5月停止积极招募,2020年8月正式结束招募。共有580名参与者加入并在队列中接受随访。在筛查、同意和完成研究活动过程中观察到了招募 - 入组级联情况。艾滋病毒检测试剂盒的实施经验表明,即使采用自动化数字程序,也需要大量工作人员参与以支持参与者的参与、访视完成和留存。
本研究回应了对数字观察性和干预性研究日益增长的研究兴趣,特别是针对受艾滋病毒疫情影响最严重的人群以及那些可能不会亲自参与研究的人群。招募 - 入组级联各阶段的进展为在线环境中实施队列研究提供了有用的见解。
国际注册报告识别码(IRRID):DERR1 - 10.2196/29152